Crosstalk between the Tumor Microenvironment and Immune System in Pancreatic Ductal Adenocarcinoma: Potential Targets for New Therapeutic Approaches

Pancreatic ductal adenocarcinoma is a lethal disease for which radical surgery and chemotherapy represent the only curative options for a small proportion of patients. Recently, FOLFIRINOX and nab-paclitaxel plus gemcitabine have improved the survival of metastatic patients but prognosis remains poo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Gastroenterol Res Pract
Egile Nagusiak: Parente, Paola, Parcesepe, Pietro, Covelli, Claudia, Olivieri, Nunzio, Remo, Andrea, Pancione, Massimo, Latiano, Tiziana Pia, Graziano, Paolo, Maiello, Evaristo, Giordano, Guido
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi 2018
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6312626/
https://ncbi.nlm.nih.gov/pubmed/30662458
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/7530619
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak